MDT

96.07

-0.39%↓

146.68

-0.14%↓

VEEV

225

-2.38%↓

HQY

84.48

+1.71%↑

PHR.US

16.26

-1.16%↓

MDT

96.07

-0.39%↓

146.68

-0.14%↓

VEEV

225

-2.38%↓

HQY

84.48

+1.71%↑

PHR.US

16.26

-1.16%↓

MDT

96.07

-0.39%↓

146.68

-0.14%↓

VEEV

225

-2.38%↓

HQY

84.48

+1.71%↑

PHR.US

16.26

-1.16%↓

MDT

96.07

-0.39%↓

146.68

-0.14%↓

VEEV

225

-2.38%↓

HQY

84.48

+1.71%↑

PHR.US

16.26

-1.16%↓

MDT

96.07

-0.39%↓

146.68

-0.14%↓

VEEV

225

-2.38%↓

HQY

84.48

+1.71%↑

PHR.US

16.26

-1.16%↓

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.01.2026 г., 19:05 ч. UTC

Значими двигатели на пазара

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13.01.2026 г., 23:41 ч. UTC

Пазарно говорене

Nikkei May Rise on Japan Election Hopes -- Market Talk

13.01.2026 г., 23:41 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

13.01.2026 г., 23:33 ч. UTC

Пазарно говорене

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13.01.2026 г., 23:13 ч. UTC

Придобивния, сливания и поглъщания

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13.01.2026 г., 23:10 ч. UTC

Придобивния, сливания и поглъщания

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13.01.2026 г., 23:03 ч. UTC

Пазарно говорене

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13.01.2026 г., 21:50 ч. UTC

Придобивния, сливания и поглъщания

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

13.01.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13.01.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13.01.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13.01.2026 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13.01.2026 г., 21:08 ч. UTC

Придобивния, сливания и поглъщания

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13.01.2026 г., 20:39 ч. UTC

Пазарно говорене

Silver Settles at Another New High -- Market Talk

13.01.2026 г., 20:21 ч. UTC

Пазарно говорене

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13.01.2026 г., 20:17 ч. UTC

Пазарно говорене

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13.01.2026 г., 19:08 ч. UTC

Придобивния, сливания и поглъщания

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13.01.2026 г., 19:03 ч. UTC

Печалби

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13.01.2026 г., 18:50 ч. UTC

Печалби

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13.01.2026 г., 17:54 ч. UTC

Пазарно говорене

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13.01.2026 г., 17:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

13.01.2026 г., 17:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13.01.2026 г., 17:49 ч. UTC

Пазарно говорене

Analysts Call For Potential Record Ethanol Output -- Market Talk

13.01.2026 г., 17:38 ч. UTC

Пазарно говорене

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

13.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

13.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

13.01.2026 г., 17:19 ч. UTC

Пазарно говорене

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13.01.2026 г., 17:15 ч. UTC

Пазарно говорене

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.